RESUMO
Experiments on male rats exhibiting both high and low resistance to hypoxia have shown that ionol acts as a cardioprotective agent in the adrenalin-induced myocardial dystrophy. This effect is realized through the depression of the lipid peroxidation activity.
Assuntos
Antioxidantes/uso terapêutico , Hidroxitolueno Butilado/uso terapêutico , Cardiomiopatias/tratamento farmacológico , Epinefrina/efeitos adversos , Peroxidação de Lipídeos/efeitos dos fármacos , Malonatos/metabolismo , Malondialdeído/metabolismo , Miocárdio/metabolismo , Animais , Cardiomiopatias/induzido quimicamente , Epinefrina/antagonistas & inibidores , Peroxidação de Lipídeos/fisiologia , Masculino , Malondialdeído/antagonistas & inibidores , RatosRESUMO
Experiments conducted on male rats with congenital high and low resistance to hypoxia (HH and LH, respectively) have revealed, that injection of prostaglandin E2 (PHE2) 15 min before the injection of adrenalin essentially decreases the activity of lipid peroxidation in myocardium as compared with animals which have been injected to only adrenalin. This modulative effect (PHE2) on the action of adrenalin was more pronounced in LH-rats. Consequently, the activity of the prostaglandin stress-limiting system determines to a great extent the organism resistance to hypoxia.